Cilostazol attenuates kainic acid-induced hippocampal cell death

Cilostazol is a selective inhibitor of type 3 phosphodiesterase (PDE3) and has been widely used as an antiplatelet agent. Cilostazol mediates this activity through effects on the cyclic adenosine monophosphate (cAMP) signaling cascade. Recently, it has attracted attention as a neuroprotective agent....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Korean J Physiol Pharmacol
Autors principals: Park, Young-Seop, Jin, Zhen, Jeong, Eun Ae, Yi, Chin-ok, Lee, Jong Youl, Park, In Sung, Roh, Gu Seob
Format: Artigo
Idioma:Inglês
Publicat: The Korean Physiological Society and The Korean Society of Pharmacology 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746513/
https://ncbi.nlm.nih.gov/pubmed/29302213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2018.22.1.63
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars